CYDY- Cytodyn Inc.
Classified under Biotechnology (Health Care sector), CYDY's insider flows are most useful compared with peers in the same group.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 4.87M | $914.0K | - | |
| CFO | 4.87M | $914.0K | - | |
| Other | 3.25M | $609.3K | - | |
| Dir | 574.4K | $107.7K | - | |
| Dir | 574.4K | $107.7K | - |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2020 | Mulholland Michael D. | Chief Financial Officer | Sale+OE | 711,801 | $6.23 | $4,437,557.19 | -34.9% | |
| Dec 21, 2020 | Mulholland Michael D. | Chief Financial Officer | Sale+OE | 1,108,799 | $5.28 | $5,849,359.56 | -56.5% | |
| Nov 2, 2020 | Naydenov Jordan G | Director | Buy | 193,500 | $2.57 | $497,295.00 | +3.1% | |
| Oct 23, 2020 | Naydenov Jordan G | Director | Buy | 120,000 | $2.49 | $298,308.00 | +2.0% | |
| Oct 23, 2020 | Colachis Arian | GC And Corporate Secretary | Buy | 10,000 | $2.50 | $25,000.00 | +14.3% | |
| May 4, 2020 | Pourhassan Nader | President &CEO | Sale+OE | 4,821,174 | $3.27 | $15,760,909.87 | -42.7% | |
| May 1, 2020 | Kelly Scott A. | Chief Medical Officer | Sale+OE | 1,200,000 | $3.26 | $3,912,480.00 | -43.5% | |
| May 1, 2020 | Kelly Scott A. | Chief Medical Officer | Buy | 250,000 | $0.57 | $141,250.00 | +15.7% | |
| Oct 21, 2016 | Pourhassan Nader | President And CEO | Buy | 15,000 | $0.66 | $9,930.00 | +2,000% | |
| Oct 17, 2016 | Mulholland Michael D. | CFO, Treasurer And Secretary | Buy | 11,000 | $0.66 | $7,238.00 | +42.2% |
Page 1Next →